Status:
COMPLETED
Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Nasopharyngeal carcinoma (NPC) differs from other head and neck malignancies terms of its epidemiology, pathology, and treatment outcome. Although NPC is a radiosensitive tumor, distant recurrence rem...
Detailed Description
1. Background: Nasopharyngeal carcinoma (NPC) differs from other head and neck malignancies terms of its epidemiology, pathology, and treatment outcome. NPC has a good local tumor control rate but...
Eligibility Criteria
Inclusion
- Biopsy proved primary M0 nasopharyngeal carcinoma
Exclusion
- Woman with pregnancy or during lactation
- A history of other malignancies or presence of recurrent tumors
- A serum glucose level \> 200mg/dL before PET scan
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2014
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04417985
Start Date
August 1 2011
End Date
July 31 2014
Last Update
August 21 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.